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Abstract
This study compared obese (N = 134) and unobese (N = 92) male blood donors, regarding the relative intensity (RI)
and activity of different molecular forms (G1, G2, G4 and G1-ALB) of butyrylcholinesterase (BChE, EC 3.1.1.8) found
in plasma, thereby searching for an association between these variables with obesity and SNPs of exons 1 and 4 of
the BCHE gene. It was shown that obese and unobese individuals do not differ in the RI of each BChE band, even
when classifying the sample into three genotypes of exons 1 and 4 of the BCHE gene (-116GG/539AA,
-116GG/539AT,- 116GA/539AT). Although the mean BChE activity of each band was significantly higher in obese
than in unobese blood donors, the proportions of BChE bands were maintained, even under the metabolic stress as-
sociated to obesity, thereby leading to infer that this proportion is somehow regulated, and may therefore be impor-
tant for BChE functions.
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Human butyrylcholinesterase (BChE; EC 3.1.1.8)
hydrolyses choline and other esters, this synthesis taking
placeintheliver,withposteriordistributiontoseveralparts
of the organism. BChE is coded by the BCHE gene
(3q26.1-q26.2) which presents four exons (Arpagaus et al.,
1990), with more than 70 already-described variants (re-
view in Souza et al., 2005b). Another type of genetic varia-
tion occurs through the interaction of products from the
BCHE and CHE2 (2q33-q35) genes, this resulting in the
CHE2 C5+ and CHE2 C5- phenotypes, characterized by
the presence and absence of the C5 complex, respectively
(Harris et al., 1962).
BChE is found in human plasma, either in homo-
meric, viz., monomers (G1), dimers (G2), trimers (G3) and
tetramers (G4) (Harris et al., 1962), or heteromeric forms
associated with other substances, such as albumin (G1-
ALB) (Masson, 1989).
Although the physiological role of BChE has not
been fully elucidated, published data suggest its relation-
ship with lipid metabolism (Kutty et al., 1977), weight
(Chautard-Freire-Maia et al., 1991; Li et al., 2008) and
body mass index (BMI) (Alcântara et al., 2001, 2003;
Souza et al., 2005a; Furtado-Alle et al., 2008). Besides
mean BChE activity tending to be higher in obese than in
unobese individuals (Chautard-Freire-Maia et al., 1991;
Alcântara et al., 2003; Furtado-Alle et al., 2008), BChE it-
selfisalsorelatedtoghrelin(Kojimaetal.,2001),apeptide
associated with obesity (Tschöp et al., 2001), through its
hydrolyzing and inactivating the latter (De Vriese et al.,
2004).
The aim was to compare the relative intensity (RI)
and activity of BChE bands (G1, G1-ALB, G2 and G4) in
obeseandcontrolindividuals,andsearchforanassociation
between the activity of each band with obesity and SNPs of
exons 1 and 4 of the BCHE gene. This research was ap-
proved by the Ethical Committee (CONEP; registration
number 2063).
The sample comprised 134 obese (BMI  30; mean
age 36.9) and 92 unobese (20  BMI < 25; mean age 35.1)
male blood donors bearing the CHE2 C5- phenotype. Indi-
viduals with any no detectable BChE band were excluded
from the study. The detection of BChE bands in plasma -
stored from eight to eleven years at -20 °C - was by means
of electrophoresis (8 h; 100V and 11 mA; 4 °C) of plasma
samples (5 L) mixed with 7 L of bromophenol blue be-
fore loading onto polyacrylamide gels (170 x 160 x
0.8mm;29:1stocksolution)of5%(1cm;stackinggel)and
7% (13 cm; resolving gel) concentrations in TBE 1X. The
bands were revealed at 37 °C after 30 to 40 min incubation
inasolutionof0.2%FastRedTRin200mMsodiumphos-
phate buffer (pH 7.1) containing 3.4% of 30 mM alpha-
naphthyl acetate dissolved in acetone, the volume being
completed with distilled water (1:1). A pre-run of 30 min
was done before plasma loading. Data concerning plasma
BChE activity (Dietz et al., 1972), as modified (Evans and
Wroe, 1978), and genotypes of exons 1 (-116GG, -116GA,
-116AA)a n d4( 539AA, 539AT, 539TT)o ft h eBCHE gene
were obtained from the data bank of the Laboratory of
Polymorphisms and Linkage (Genetics Department,
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Short CommunicationUFPR), most of which part of a previous study (Furtado-
Alle et al., 2008). The activity of each band was a result of
the multiplication of plasma BChE activity by the RI of
eachBChEbanddetectedinthepolyacrylamidegel,subse-
quently measured by optical densitometry with KODAK
1D Image Analysis Software. Statistica for Windows
(StatSoft, Inc., 5.5 version, 2000) was used for statistical
analysis.
Mean BChE activity in plasma, as estimated for the
present sample, was significantly higher in obese
(6.51  2.87) than in unobese men (4.61  1.11; t = 6,949,
p=6x10
-11).Table1showsthatobeseandcontrolindivid-
uals do not differ in the proportions of each BChE band, al-
though the activity of each band is significantly higher in
obese than in unobese men, with ratios varying from 1.32
(G1-ALB) to 1.63 (G1). When classified according to the
more frequent genotypes, mean BChE activity in plasma is
significantly higher in obese than unobese individuals,
respectively: -116GG/539AA (N = 80, 6.58  2.66 and
N = 54, 5.02  1.10; t = 4.67,p<1 0
-5), -116GG/539AT
(N = 20, 7.08  3.91 and N = 12, 3.96  1.05; t = 3.37,
p < 0.005) and -116GA/539AT (N = 19, 5.22  2.22 and
N = 12, 3.95  0.78; t = 2.26, p < 0.05). As to RI means of
BChE bands, classified according to these genotypes, no
significant difference between obese and control individu-
als was revealed through t-tests (data not shown).
TheKmutation(539T)oftheBCHEgenewasassoci-
ated with lower BChE activity (Rubinstein et al., 1978),
anditwasshownthatthe-116ASNPispreferentiallyfound
in cis combination with the 539T variant (Bartels et al.,
1990). Recently, it was reported that the 539T SNP alone is
not associated with decreased BChE activity, since this re-
quires the 5’ UTR -116A variant, probably through the lat-
ter affecting transcription and/or translation of the BCHE
gene (Furtado-Alle et al., 2008). From the present data, it
can be seen that obese and control samples, grouped by ge-
notypes of exons 1 and 4 of the BCHE gene, revealed simi-
lar RI of each BChE band. Therefore, the reduced plasma
BChE activity associated with genotype -116GA/539AT
(Furtado-Alle et al., 2008) does not seem to affect the RI of
the BChE molecular forms examined.
On considering the encountered similarity of RI in
each BChE band in obese and control subjects, the higher
mean activity of each band in the former can be attributed
solelytohigherBChEplasmaactivity.Eventhoughthisac-
tivity is higher in obese individuals and lower in the
-116GA/539AT genotype than in others, from the data, it
can be seen that the RI of each band is maintained, inde-
pendently of obesity and the examined genotypes, suggest-
ing that this proportion is regulated, and may therefore be
important for BChE function(s).
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